{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:50:15Z","timestamp":1793065815384,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2021\/001009"],"award-info":[{"award-number":["CRG\/2021\/001009"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phymed.2025.157448","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:27:34Z","timestamp":1761355654000},"page":"157448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-754X","authenticated-orcid":false,"given":"Zuber","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam Das","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/neurolint17040056","article-title":"Neurofilament light chain and multiple sclerosis: building a neurofoundational model of biomarkers and diagnosis","volume":"17","author":"Aburashed","year":"2025","journal-title":"Neurol. Int."},{"key":"10.1016\/j.phymed.2025.157448_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1500770","article-title":"Natural killer cells in multiple sclerosis: foe or friends?","volume":"19","author":"Aghaee","year":"2025","journal-title":"Front. Cell Neurosci."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01942-8","article-title":"White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments","volume":"11","author":"Akaishi","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acschemneuro.2c00589","article-title":"Exploring the role of neurotransmitters in multiple sclerosis: an expanded review","volume":"14","author":"Akyuz","year":"2023","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13578-023-00966-z","article-title":"Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome","volume":"13","author":"Arjunan","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phymed.2025.157448_bib0006","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fnins.2019.01026","article-title":"Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients","volume":"13","author":"Bai","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.phymed.2025.157448_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2022.102296","article-title":"4-hydroxyisoleucine mediated IGF-1\/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats","volume":"96","author":"Bhalla","year":"2022","journal-title":"Neuropeptides"},{"issue":"10","key":"10.1016\/j.phymed.2025.157448_bib0008","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.3390\/ijms26104623","article-title":"The role of oligodendrocytes in neurodegenerative diseases: unwrapping the layers","volume":"26","author":"Bokulic Panichi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phymed.2025.157448_bib0010","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/brain\/awv209","article-title":"Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis","volume":"138","author":"Cawley","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.phymed.2025.157448_bib0011","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jocn.2020.09.054","article-title":"Semaglutide-mediated protection against A\u03b2 correlated with enhancement of autophagy and inhibition of apotosis","volume":"81","author":"Chang","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, immunity, and disease","volume":"75","author":"Channer","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2025.157448_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578200","article-title":"Matrine mediated neuroprotective potential in experimental multiple sclerosis: evidence from CSF, blood markers, brain samples and in-silico investigations","volume":"384","author":"Chhabra","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"Suppl 1","key":"10.1016\/j.phymed.2025.157448_bib0014","first-page":"S69","article-title":"What we learned from the history of multiple sclerosis measurement: expanded disability status scale","volume":"55","author":"Cinar","year":"2018","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.phymed.2025.157448_bib0015","article-title":"Platelet-to-lymphocyte ratio differs between MS and NMOSD at disease onset and predict disability","volume":"58","author":"Contentti","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.phymed.2025.157448_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1135540","article-title":"Central nervous system demyelinating diseases: glial cells at the hub of pathology","volume":"14","author":"Coutinho Costa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2025.157448_bib0018","article-title":"Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection","volume":"4","author":"Dharmashekara","year":"2021","journal-title":"Environ Chall."},{"issue":"10","key":"10.1016\/j.phymed.2025.157448_bib0020","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","article-title":"The expanding incretin universe: from basic biology to clinical translation","volume":"66","author":"Drucker","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.phymed.2025.157448_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1033479","article-title":"The mechanism and efficacy of GLP-1 receptor agonists in the treatment of alzheimer\u2019s disease","volume":"13","author":"Du","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phymed.2025.157448_bib0022","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnins.2014.00145","article-title":"Oligodendrogenesis in the normal and pathological central nervous system","volume":"8","author":"El Waly","year":"2014","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0023","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/jnc.15884","article-title":"Cerebrospinal fluid, brain, and spinal cord levels of l-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model","volume":"166","author":"Errico","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phymed.2025.157448_bib0024","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ecoenv.2013.12.017","article-title":"Assessment of ethidium bromide and ethidium monoazide bromide removal from aqueous matrices by adsorption on cupric oxide nanoparticles","volume":"104","author":"Fakhri","year":"2014","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in alzheimer\u2019s disease: study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.phymed.2025.157448_bib0026","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/cells10113177","article-title":"Lymphocyte counts and multiple sclerosis therapeutics: between mechanisms of action and treatment-limiting side effects","volume":"10","author":"Fischer","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0027","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/molecules22060959","article-title":"3D pharmacophore-based virtual screening and docking approaches toward the discovery of novel HPPD inhibitors","volume":"22","author":"Fu","year":"2017","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.phymed.2025.157448_bib0028","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0029","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/biomedicines8060153","article-title":"Possible correlation between cholinergic system alterations and neuro\/inflammation in multiple sclerosis","volume":"8","author":"Gatta","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/cells11040666","article-title":"Research progress on neuroprotection of insulin-like growth factor-1 towards glutamate-induced neurotoxicity","volume":"11","author":"Ge","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0031","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s13311-021-01088-5","article-title":"Therapeutic potential of a novel glucagon-like peptide-1 receptor agonist, NLY01, in experimental autoimmune encephalomyelitis","volume":"18","author":"Gharagozloo","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phymed.2025.157448_bib0032","first-page":"1431","article-title":"The laboratory rat: age and body weight matter","volume":"20","author":"Ghasemi","year":"2021","journal-title":"EXCLI. J."},{"key":"10.1016\/j.phymed.2025.157448_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115831","article-title":"Melatonin-mediated IGF-1\/GLP-1 activation in experimental OCD rats: evidence from CSF, blood plasma, brain and in-silico investigations","volume":"217","author":"Giri","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0034","first-page":"63","article-title":"Focal injection of ethidium bromide as a simple model to study cognitive deficit and its improvement","volume":"7","author":"Goudarzvand","year":"2016","journal-title":"Basic Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1476-5381.2009.00256.x","article-title":"IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions","volume":"157","author":"Guan","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.phymed.2025.157448_bib0036","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of alzheimer\u2019s disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.phymed.2025.157448_bib0037","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/ml100044h","article-title":"Allosteric IGF-1R inhibitors","volume":"1","author":"Heinrich","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phymed.2025.157448_bib0038","doi-asserted-by":"crossref","unstructured":"Herrera, M.L., Champarini, L.G., Oliveros, A.L., Bellini, M.J. and Here\u00f1\u00fa, C.B., 2024. Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review.","DOI":"10.37349\/ent.2024.00093"},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0042","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12929-024-01090-x","article-title":"Role of glucagon-like peptide-1 receptor agonists in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"31","author":"Hong","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0043","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/encyclopedia2040111","article-title":"Apoptosis regulators bcl-2 and caspase-3","volume":"2","author":"Hussar","year":"2022","journal-title":"Encyclo"},{"issue":"11","key":"10.1016\/j.phymed.2025.157448_bib0044","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/acs.chemrestox.4c00378","article-title":"The intercalator ethidium bromide generates covalent adducts at apurinic\/apyrimidinic aites in DNA","volume":"37","author":"Islam","year":"2024","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-023-01535-8","article-title":"Insulin-like growth factor-1 receptor controls the function of CNS-resident macrophages and their contribution to neuroinflammation","volume":"11","author":"Ivan","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.phymed.2025.157448_bib0046","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.3390\/ijms25073812","article-title":"GLP-1 receptor agonists: a new treatment in parkinson\u2019s disease","volume":"25","author":"Kalinderi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl 3","key":"10.1016\/j.phymed.2025.157448_bib0047","first-page":"S388","article-title":"Effects of 4-hydroxyisoleucine from fenugreek seeds on depression-like behavior in socially isolated olfactory bulbectomized rats","volume":"11","author":"Kalshetti","year":"2015","journal-title":"Pharmacogn. Mag."},{"issue":"18","key":"10.1016\/j.phymed.2025.157448_bib0048","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3390\/cells11182771","article-title":"Forskolin, an adenylcyclase\/cAMP\/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis","volume":"11","author":"Kapoor","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.phymed.2025.157448_bib0049","article-title":"The role of glucagon-like peptide-1 agonists in the treatment of multiple sclerosis: a narrative review","volume":"16","author":"Kaye","year":"2024","journal-title":"Cureus"},{"issue":"14","key":"10.1016\/j.phymed.2025.157448_bib0050","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.3390\/ijms23147584","article-title":"The possible role of neural cell apoptosis in multiple sclerosis","volume":"23","author":"Kennedy","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2025.157448_bib0051","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s12035-024-04351-w","article-title":"Synthesis and neurobehavioral evaluation of a potent multitargeted inhibitor for the treatment of alzheimer\u2019s disease","volume":"62","author":"Khan","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"13","key":"10.1016\/j.phymed.2025.157448_bib0053","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.3390\/jcm12134274","article-title":"Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges","volume":"12","author":"Khan","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phymed.2025.157448_bib0054","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuroscience.2024.04.004","article-title":"Immune system dysregulation in the progression of multiple sclerosis: molecular insights and therapeutic implications","volume":"548","author":"Khan","year":"2024","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.phymed.2025.157448_bib0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/0115672050289946240223050737","article-title":"Proton pump inhibitors and cognitive health: review on unraveling the dementia connection and co-morbid risks","volume":"20","author":"Khan","year":"2023","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.phymed.2025.157448_bib0056","article-title":"Measuring locomotor activity and behavioral aspects of rodents living in the home-cage","volume":"16","author":"Klein","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.phymed.2025.157448_bib0057","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.phymed.2025.157448_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.157448_bib0059","first-page":"1308","article-title":"Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis","volume":"20","author":"Kouchaki","year":"2021","journal-title":"EXCLI. J."},{"issue":"5","key":"10.1016\/j.phymed.2025.157448_bib0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11011-021-00691-x","article-title":"Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain","volume":"36","author":"Kumar","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0061","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/0118715273336107241015100912","article-title":"Enhanced neuroprotection in experiment multiple sclerosis through combined rosiglitazone and probiotic-loaded solid lipid nanoparticles: modulation of cellular signaling pathways","volume":"24","author":"Kumar","year":"2025","journal-title":"CNS Neurol. Disord. Drug Targets."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0062","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40203-023-00157-1","article-title":"In-silico identification of small molecule benzofuran-1, 2, 3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies","volume":"11","author":"Kumar","year":"2023","journal-title":"In Silico Pharmacol."},{"issue":"18","key":"10.1016\/j.phymed.2025.157448_bib0063","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1080\/07391102.2023.2252496","article-title":"In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1, 2, 3-triazole hybrids as novel EGFR inhibitors targeting lung cancer","volume":"42","author":"Kumar","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.phymed.2025.157448_bib0064","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/aian.AIAN_33_18","article-title":"Evolving landscape of multiple sclerosis in India: challenges in the management","volume":"21","author":"Kumar","year":"2018","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"21","key":"10.1016\/j.phymed.2025.157448_bib0065","doi-asserted-by":"crossref","first-page":"11353","DOI":"10.1080\/07391102.2023.2204360","article-title":"Identification and exploration of quinazoline-1, 2, 3-triazole inhibitors targeting EGFR in lung cancer","volume":"41","author":"Kumar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"17","key":"10.1016\/j.phymed.2025.157448_bib0066","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1080\/08927022.2023.2256624","article-title":"In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer","volume":"49","author":"Kumar","year":"2023","journal-title":"Mol. Simul."},{"issue":"21","key":"10.1016\/j.phymed.2025.157448_bib0067","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.0000000000200258","article-title":"Blood neurofilament light in progressive multiple sclerosis: post hoc analysis of 2 randomized controlled trials","volume":"98","author":"Leppert","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0068","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11154-021-09699-1","article-title":"Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes","volume":"23","author":"Mahapatra","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.phymed.2025.157448_bib0069","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.7150\/ijbs.84353","article-title":"IGF\/IGF-1R signal pathway in pain: a promising therapeutic target","volume":"19","author":"Ma","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0070","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.3390\/ijerph18063318","article-title":"The impact of multiple sclerosis disease status and subtype on hematological profile","volume":"18","author":"Miller","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"7","key":"10.1016\/j.phymed.2025.157448_bib0071","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00706-023-03076-1","article-title":"Molecular docking in organic, inorganic, and hybrid systems: a tutorial review","volume":"154","author":"Mohanty","year":"2023","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.phymed.2025.157448_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106209","article-title":"Demyelination in psychiatric and neurological disorders: mechanisms, clinical impact, and novel therapeutic strategies","author":"Murayama","year":"2025","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"20","key":"10.1016\/j.phymed.2025.157448_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010931","article-title":"Selected interleukins relevant to multiple sclerosis: new directions, potential targets and therapeutic perspectives","volume":"25","author":"Mado","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0074","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/children10061022","article-title":"Multiple sclerosis\u2014related dietary and nutritional issues: an updated scoping review with a focus on pediatrics","volume":"10","author":"Mandato","year":"2023","journal-title":"Children"},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000533527","article-title":"A global, regional, and national survey on burden and quality of care index of multiple sclerosis: global burden of disease systematic analysis 1990\u20132019","volume":"57","author":"Maroufi","year":"2023","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0077","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008656","article-title":"Caspase functions in cell death and disease","volume":"5","author":"McIlwain","year":"2013","journal-title":"Cold. Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0079","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s12035-024-04457-1","article-title":"Insulin-like growth factor signaling in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"62","author":"Miao","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phymed.2025.157448_bib0080","article-title":"Model systems to define remyelination therapies","volume":"125","author":"Miller","year":"2018","journal-title":"Neuroplasticity: Insights Neural Reorgan."},{"issue":"8","key":"10.1016\/j.phymed.2025.157448_bib0081","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jnnp-2013-306662","article-title":"Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions","volume":"85","author":"Muhlert","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0082","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12964-023-01324-9","article-title":"Natural killer cells in the central nervous system","volume":"21","author":"Ning","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0083","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029058","article-title":"Biomarkers in multiple sclerosis","volume":"9","author":"Paul","year":"2019","journal-title":"Cold. Spring Harb. Perspect. Med."},{"key":"10.1016\/j.phymed.2025.157448_bib0084","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.mex.2019.07.005","article-title":"Stereotaxic surgery for implantation of guide cannulas for microinjection into the dorsomedial hypothalamus in young rats","volume":"6","author":"Poole","year":"2019","journal-title":"MethodsX"},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0085","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1007\/s11064-023-04082-9","article-title":"Purmorphamine, a Smo-Shh\/Gli activator, promotes sonic hedgehog-mediated neurogenesis and restores behavioural and neurochemical deficits in experimental model of multiple sclerosis","volume":"49","author":"Prajapati","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phymed.2025.157448_bib0086","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.phymed.2025.157448_bib0087","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1212\/WNL.0000000000001281","article-title":"Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis","volume":"84","author":"Radue","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.phymed.2025.157448_bib0090","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.3168\/jds.2013-7736","article-title":"Evaluation of an automated in-house hematology analyzer for bovine blood","volume":"97","author":"Roland","year":"2014","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.phymed.2025.157448_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00712","article-title":"From metabolism to mind: the expanding role of the GLP-1 receptor in neurotherapeutics","author":"Roy","year":"2025","journal-title":"Neurotherapeutics."},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0092","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00281-019-00765-0","article-title":"Resolution of inflammation during multiple sclerosis","volume":"41","author":"Ruiz","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.phymed.2025.157448_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109647","article-title":"Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: involvement of the PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"115","author":"Sadek","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2025.157448_bib0094","first-page":"1","article-title":"Neuroprotective effects of gastrodin against bisphenol A induced-ADHD-like symptoms in rats","author":"Saifi","year":"2025","journal-title":"Drug Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.phymed.2025.157448_bib0096","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.phymed.2025.157448_bib0039","article-title":"Multiple sclerosis and serotonin: potential therapeutic applications","volume":"12","author":"San Hernandez","year":"2020","journal-title":"Cureus"},{"issue":"1\u20132","key":"10.1016\/j.phymed.2025.157448_bib0097","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-5728(01)00464-7","article-title":"Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins","volume":"122","author":"Semra","year":"2002","journal-title":"J. Neuroimmunol."},{"issue":"12","key":"10.1016\/j.phymed.2025.157448_bib0098","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.3390\/molecules27123878","article-title":"Activation of IGF-1\/GLP-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental ALS-rats exposed to methylmercury-induced neurotoxicity","volume":"27","author":"Shandilya","year":"2022","journal-title":"Molecules"},{"issue":"1\u20132","key":"10.1016\/j.phymed.2025.157448_bib0099","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(02)00024-3","article-title":"The expression of pro-and anti-apoptosis bcl-2 family proteins in lymphocytes from patients with multiple sclerosis","volume":"125","author":"Sharief","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.phymed.2025.157448_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2025.110415","article-title":"Enhancing therapeutic efficacy of fingolimod via intranasal delivery in an ethidium bromide-induced model of multiple sclerosis","volume":"418","author":"Sharma","year":"2025","journal-title":"J. Neurosci. Methods"},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100051","article-title":"Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats","volume":"1","author":"Sharma","year":"2021","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.phymed.2025.157448_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113537","article-title":"Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative disorders: a large-scale propensity-matched cohort study","volume":"143","author":"Siddeeque","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.phymed.2025.157448_bib0078","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1016\/j.sjbs.2021.07.010","article-title":"Neuroprotective efficacy of 4-hydroxyisoleucine in experimentally induced intracerebral hemorrhage","volume":"28","author":"Siddiqui","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2025.157448_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100139","article-title":"Inhibition of c-JNK\/p38MAPK signaling pathway by apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: evidence from CSF, blood plasma and brain samples","volume":"1","author":"Singh","year":"2021","journal-title":"Phytomed. Plus"},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0104","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.phymed.2025.157448_bib0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/cns.13791","article-title":"Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway","volume":"28","author":"Song","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.phymed.2025.157448_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2023.109971","article-title":"Simple methods for cerebrospinal fluid collection in fetal, neonatal, and adult rat","volume":"399","author":"Tavakkoli","year":"2023","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.phymed.2025.157448_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103535","article-title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","volume":"59","author":"Thebault","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.phymed.2025.157448_bib0108","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/genes13081324","article-title":"Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis","volume":"13","author":"Upadhayay","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.phymed.2025.157448_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103590","article-title":"NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study","volume":"72","author":"Uphaus","year":"2021","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.phymed.2025.157448_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1567205020666230525154300","article-title":"Pharmacological attributes of fenugreek with special reference to Alzheimer\u2019s disease","volume":"20","author":"Varshney","year":"2023","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.phymed.2025.157448_bib0111","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jssas.2016.01.007","article-title":"Fenugreek: a review on its nutraceutical properties and utilization in various food products","volume":"17","author":"Wani","year":"2018","journal-title":"J. Saudi Soc. Agric. Sci."},{"issue":"12","key":"10.1016\/j.phymed.2025.157448_bib0112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190456","article-title":"Mitochondrial DNA depletion by ethidium bromide decreases neuronal mitochondrial creatine kinase: implications for striatal energy metabolism","volume":"12","author":"Warren","year":"2017","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.phymed.2025.157448_bib0113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914882","article-title":"The IGF1 signaling pathway: from basic concepts to therapeutic opportunities","volume":"24","author":"Werner","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.phymed.2025.157448_bib0114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119317","article-title":"Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane","volume":"1869","author":"Wolf","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.phymed.2025.157448_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104615","article-title":"Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure","volume":"152","author":"Yoon","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.157448_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155248","article-title":"Natural compounds as potential therapeutic candidates for multiple sclerosis: emerging preclinical evidence","volume":"123","author":"Yuan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.157448_bib0088","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuroscience.2024.12.029","article-title":"A review on multiple sclerosis: unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations","volume":"567","author":"Zainab","year":"2025","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.phymed.2025.157448_bib0117","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3390\/ijms26073258","article-title":"Profiling blood-based neural biomarkers and cytokines in experimental autoimmune encephalomyelitis model of multiple sclerosis using single-molecule array technology","volume":"26","author":"Zahoor","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0118","first-page":"157","article-title":"Semaglutide is neuroprotective and reduces \u03b1-synuclein levels in the chronic MPTP mouse model of parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2019","journal-title":"Parkinsons. Dis."},{"issue":"7657","key":"10.1016\/j.phymed.2025.157448_bib0119","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature22394","article-title":"Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein","volume":"546","author":"Zhang","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phymed.2025.157448_bib0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325010852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325010852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:14:55Z","timestamp":1769811295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325010852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":111,"alternative-id":["S0944711325010852"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157448","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of 4-hydroxyisoleucine in experimental rat model of demyelination: Neuroprotection through IGF-1 and GLP-1 level restoration","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157448"}}